Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Gossamer Bio Inc. (GOSS) Misses Q1 EPS by 7c
May 12, 2020 4:26 PM EDTGossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.87), $0.07 worse than the analyst estimate of ($0.80).
We are very pleased today to share initial results of the Gossamer teams great execution and hard work, including that we have successfully completed the interim analysis of the LEDA study of GB001, said Sheila Gujrathi, M.D., Co-Founder and Chief Executive Officer of Gossamer. We have begun initial Phase 3 planning and supportive activities, while awaiting final... More
